Iotalamic acid
 | |
 | |
| Clinical data | |
|---|---|
| Trade names | Conray, Glofil-125, Cysto-Conray II, others |
| Other names | MI-216, iothalamate meglumine, Iothalamic acid (USAN US) |
| AHFS/Drugs.com | Consumer Drug Information |
| License data |
|
Intravascular[1] | |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
JSmol) | |
| |
| |
Iotalamic acid, sold under the brand name Conray, is an
urinary bladder).[1]
A radioactive formulation is also available as sodium iothalamate
glomerular filtration in the diagnosis or monitoring of people with kidney disease.[2]
References
- ^ a b c "Conray- iothalamate meglumine injection". DailyMed. 1 January 2021. Retrieved 23 February 2022.
- ^ a b "Glofil-125- sodium iothalamate i-125 injection injection, solution". DailyMed. 9 December 2019. Retrieved 23 February 2022.
- ^ "Cysto-Conray II- iothalamate meglumine injection". DailyMed. 31 December 2020. Retrieved 23 February 2022.
External links
- "Iothalamate meglumine". Drug Information Portal. U.S. National Library of Medicine.
- "Iothalamate sodium". Drug Information Portal. U.S. National Library of Medicine.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |